Literature DB >> 23518782

Schizophrenia: a systemic disorder.

Brian Kirkpatrick1, Brian Miller2, Clemente García-Rizo3, Emilio Fernandez-Egea4.   

Abstract

The concept of schizophrenia that is most widely taught is that it is a disorder in which psychotic symptoms are the main problem, and a dysregulation of dopamine signaling is the main feature of pathophysiology. However, this concept limits clinical assessment, the treatments offered to patients, research, and the development of therapeutics. A more appropriate conceptual model is that: 1) schizophrenia is not a psychotic disorder, but a disorder of essentially every brain function in which psychosis is present; 2) it is not a brain disease, but a disorder with impairments throughout the body; 3) for many patients, neuropsychiatric problems other than psychosis contribute more to impairment in function and quality of life than does psychosis; and, 4) some conditions that are considered to be comorbid are integral parts of the illness. In conclusion, students, patients, and family members should be taught this model, along with its implications for assessment, research, and therapeutics.

Entities:  

Keywords:  Dopamine; Endophenotype; Neurodevelopment; Psychosis; Schizophrenia

Mesh:

Year:  2014        PMID: 23518782      PMCID: PMC4390134          DOI: 10.3371/CSRP.KIMI.031513

Source DB:  PubMed          Journal:  Clin Schizophr Relat Psychoses        ISSN: 1935-1232


  122 in total

1.  Obstetric complications and schizophrenia: historical and meta-analytic review.

Authors:  Mary Cannon; Peter B Jones; Robin M Murray
Journal:  Am J Psychiatry       Date:  2002-07       Impact factor: 18.112

2.  Schizophrenia: The drug deadlock.

Authors:  Alison Abbott
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

Review 3.  Epidemiological comparison of schizophrenia and bipolar disorder.

Authors:  E F Torrey
Journal:  Schizophr Res       Date:  1999-09-29       Impact factor: 4.939

4.  Implications of normal brain development for the pathogenesis of schizophrenia.

Authors:  D R Weinberger
Journal:  Arch Gen Psychiatry       Date:  1987-07

5.  Panic attacks in chronic schizophrenia.

Authors:  N Argyle
Journal:  Br J Psychiatry       Date:  1990-09       Impact factor: 9.319

6.  Panic disorder in schizophrenia.

Authors:  L A Labbate; P C Young; G W Arana
Journal:  Can J Psychiatry       Date:  1999-06       Impact factor: 4.356

7.  Generalized cognitive deficits in schizophrenia: a study of first-episode patients.

Authors:  S Mohamed; J S Paulsen; D O'Leary; S Arndt; N Andreasen
Journal:  Arch Gen Psychiatry       Date:  1999-08

8.  Palate and dentition in schizophrenia.

Authors:  Brian Kirkpatrick; Gary D Hack; Erik Higginbottom; Daniel Hoffacker; Emilio Fernandez-Egea
Journal:  Schizophr Res       Date:  2007-02-21       Impact factor: 4.939

9.  Minor physical anomalies in patients with schizophrenia and their parents: prevalence and pattern of craniofacial abnormalities.

Authors:  David Gourion; Céline Goldberger; Marie-Chantal Bourdel; Frank Jean Bayle; Henri Lôo; Marie-Odile Krebs
Journal:  Psychiatry Res       Date:  2004-01-30       Impact factor: 3.222

10.  Diabetes or prediabetes in newly diagnosed patients with nonaffective psychosis? A historical and contemporary view.

Authors:  Emilio Fernandez-Egea; Clemente Garcia-Rizo; Jorge Zimbron; Brian Kirkpatrick
Journal:  Schizophr Bull       Date:  2012-11-15       Impact factor: 9.306

View more
  9 in total

Review 1.  Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naïve patients with nonaffective psychosis.

Authors:  Anne Marie Greenhalgh; Leticia Gonzalez-Blanco; Clemente Garcia-Rizo; Emilio Fernandez-Egea; Brian Miller; Miguel Bernardo Arroyo; Brian Kirkpatrick
Journal:  Schizophr Res       Date:  2016-10-17       Impact factor: 4.939

Review 2.  A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders.

Authors:  Shokufeh Ghasemian Sorboni; Hanieh Shakeri Moghaddam; Reza Jafarzadeh-Esfehani; Saman Soleimanpour
Journal:  Clin Microbiol Rev       Date:  2022-01-05       Impact factor: 26.132

3.  An integrative study of the microbiome gut-brain-axis and hippocampal inflammation in psychosis: Persistent effects from mode of birth.

Authors:  Peter Joe; Jose C Clemente; Enrica Piras; David S Wallach; Jessica Robinson-Papp; Emeka Boka; Brooke Remsen; Mharisi Bonner; David Kimhy; Deborah Goetz; Kevin Hoffman; Jakleen Lee; Eugene Ruby; Sarah Fendrich; Oded Gonen; Dolores Malaspina
Journal:  Schizophr Res       Date:  2021-10-06       Impact factor: 4.662

Review 4.  Are Essential Trace Elements Effective in Modulation of Mental Disorders? Update and Perspectives.

Authors:  Mehran Shayganfard
Journal:  Biol Trace Elem Res       Date:  2021-04-27       Impact factor: 3.738

Review 5.  The Obesity-Impulsivity Axis: Potential Metabolic Interventions in Chronic Psychiatric Patients.

Authors:  Adonis Sfera; Carolina Osorio; Luzmin Acosta Inderias; Victoria Parker; Amy I Price; Michael Cummings
Journal:  Front Psychiatry       Date:  2017-02-13       Impact factor: 4.157

6.  Hyperprolactinemia and insulin resistance in drug naive patients with early onset first episode psychosis.

Authors:  Maria Giuseppina Petruzzelli; Mariella Margari; Antonia Peschechera; Concetta de Giambattista; Andrea De Giacomo; Emilia Matera; Francesco Margari
Journal:  BMC Psychiatry       Date:  2018-08-01       Impact factor: 3.630

7.  Metagenome-wide association of gut microbiome features for schizophrenia.

Authors:  Feng Zhu; Yanmei Ju; Wei Wang; Qi Wang; Ruijin Guo; Qingyan Ma; Qiang Sun; Yajuan Fan; Yuying Xie; Zai Yang; Zhuye Jie; Binbin Zhao; Liang Xiao; Lin Yang; Tao Zhang; Junqin Feng; Liyang Guo; Xiaoyan He; Yunchun Chen; Ce Chen; Chengge Gao; Xun Xu; Huanming Yang; Jian Wang; Yonghui Dang; Lise Madsen; Susanne Brix; Karsten Kristiansen; Huijue Jia; Xiancang Ma
Journal:  Nat Commun       Date:  2020-03-31       Impact factor: 14.919

Review 8.  Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity.

Authors:  C Gragnoli; G M Reeves; J Reazer; T T Postolache
Journal:  Transl Psychiatry       Date:  2016-04-19       Impact factor: 6.222

9.  Microvascular dysfunction in schizophrenia: a case-control study.

Authors:  Martin W Vetter; Billie-Jean Martin; Marinda Fung; Milada Pajevic; Todd J Anderson; Thomas J Raedler
Journal:  NPJ Schizophr       Date:  2015-07-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.